Definition and epidemiology of late presentation in Europe

Antiviral Therapy

Volumn 15, Issue SUPPL. 1, 2010, Pages 3-8

  Johnson, Margaret ^a   Sabin, Caroline ^b   Girardi, Enrico ^c  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGE DISTRIBUTION; CD4 LYMPHOCYTE COUNT; ETHNICITY; EUROPE; HETEROSEXUAL FEMALE; HETEROSEXUAL MALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTRAVENOUS DRUG ABUSE; MALE HOMOSEXUAL; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEXUAL BEHAVIOR; VIRUS LOAD;

AIDS SERODIAGNOSIS; CLINICAL TRIALS AS TOPIC; EUROPE; HIV INFECTIONS; HUMANS; INCIDENCE; TIME FACTORS;

EID: 77952042483     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1522     Document Type: Review

References (29)

1. Centers for Disease Control and Prevention (CDC). Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. MMWR Recomm Rep 1999; 48:1-28.
2. European Centre for Disease Prevention and Control. HIV/AIDS surveillance in Europe 2007. Stockholm: European Centre for Disease Prevention and Control; 2008.
3. Hamers FF, Phillips AN. Diagnosed and undiagnosed HIV-infected populations in Europe. HIV Med 2008; 9 Suppl 2:6-12.
4. Egger M. Outcomes of ART in resource-limited and industrialized countries. 14th Conference on Retroviruses and Opportunistic Infections. 25-28 February 2007, Los Angeles, CA, USA. Abstract 62.
5. Adler A, Mounier-Jack S, Coker RJ. Late diagnosis of HIV in Europe: definitional and public health challenges. AIDS Care 2009; 21:284-293.
6. Sullivan AK, Curtis H, Sabin CA, Johnson MA. Newly diagnosed HIV infections: review in UK and Ireland. BMJ 2005; 330:1301-1302. (Pubitemid 40813561)
7. Clumeck N, Pozniak A, Raffi F. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults. HIV Med 2008; 9:65-71. (Pubitemid 351228129)
8. The Strategies for Management of Antiretroviral Therapy (SMART) Study Group. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. J Infect Dis 2008; 197:1133-1144.
9. Gazzard BG. British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. HIV Med 2008; 9:563-608.
10. Hammer SM, Eron JJ, Jr., Reiss P, et al. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA 2008; 300:555-570.
11. Panel on antiretroviral guidelines for adults and adolescents: Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. (Updated 1 December 2009. Accessed 16 March 2010.) Available from http://www.aidsinfo.nih.gov/ContentFiles/ AdultandAdolescentGL.pdf
12. When To Start Consortium. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 2009; 373:1352-1363.
13. Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009; 360:1815-1826.
14. National Institute of Allergy and Infectious Diseases (NIAID). START: Strategic timing of antiretroviral treatment. (Updated 3 February 2010. Accessed 16 March 2010.) Available from http://www.clinicaltrials.gov/ct2/show/study/ NCT00867048?term=strategic+timing+of+antiretroviral+treatment&rank=1
15. Wolbers M, Bucher HC, Furrer H, et al. Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. HIV Med 2008; 9:397-405. (Pubitemid 352015643)
16. Brannstrom J, Akerlund B, Arneborn M, Blaxhult A, Giesecke J. Patients unaware of their HIV infection until AIDS diagnosis in Sweden 1996-2002 - a remaining problem in the highly active antiretroviral therapy era. Int J STD AIDS 2005; 16:702-706.
17. Castilla J, Sobrino P, De La Fuente L, Noguer I, Guerra L, Parras F. Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence. AIDS 2002; 16:1945-1951.
18. Delpierre C, Lauwers-Cances V, Pugliese P, et al. Characteristics trends, mortality and morbidity in persons newly diagnosed HIV positive during the last decade: the profile of new HIV diagnosed people. Eur J Public Health 2008; 18:345-347. (Pubitemid 351786632)
19. Sabin CA, Smith CJ, Gumley H, et al. Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy. AIDS 2004; 18:2145-2151. (Pubitemid 39463679)
20. Borghi V, Girardi E, Bellelli S, et al. Late presenters in an HIV surveillance system in Italy during the period 1992-2006. J Acquir Immune Defic Syndr 2008; 49:282-286.
21. Lanoy E, Mary-Krause M, Tattevin P, et al. Frequency, determinants and consequences of delayed access to care for HIV infection in France. Antivir Ther 2007; 12:89-96. (Pubitemid 46340430)
22. Health Protection Agency. HIV in the United Kingdom: 2008 Report. London: Health Protection Agency; 2008.
23. Begovac J, Gedike K, Lukas D, Lepej SZ. Late presentation to care for HIV infection in Croatia and the effect of interventions during the Croatian Global Fund Project. AIDS Behav 2008; 12:S48-S53.
24. Delpierre C, Dray-Spira R, Cuzin L, et al. Correlates of late HIV diagnosis: implications for testing policy. Int J STD AIDS 2007; 18:312-317. (Pubitemid 351739001)
25. Yazdanpanah Y, Lange J, Gerstoft J, Cairns G. Earlier testing for HIV - how do we prevent late presentation. Antvir Ther 2010; 15 Suppl 1:17-24.
26. CASCADE Collaboration. Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era. AIDS 2004; 18:51-58.
27. HIV in Europe. Working together for optimal testing and earlier care. Stockholm, Sweden, 2-3 November 2009. (Updated 10 February 2010. Accessed 25 March 2010). Available from http://hiveurope.eu/LinkClick.aspx?fileticket= b8%2FJ9PBrkqE%3D&tabid=37
28. Gatell J. How to implement a consensus definition of 'late presentation'. HIV in Europe 2009. 1-2 November 2009, Stockholm, Sweden. (Updated 2 November 2009. Accessed 25 March 2010.) Available from http://bambuser.com/channel/ HIVinEurope/broadcast/314113
29. Stohr W, Dunn D, Porter K, et al. CD4 cell count and initiation of antiretroviral therapy: trends in seven UK centres, 1997-2003. HIV Med 2007; 8:135-141.